Clindamycin Hydrochloride
Clindamycin Hydrochloride is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Clindamycin Hydrochloride; Generic name: CLINDAMYCIN HYDROCHLORIDE; Manufacturer: NuCare Pharmaceuticals,Inc..
| Brand name | Clindamycin Hydrochloride |
|---|---|
| Generic name | CLINDAMYCIN HYDROCHLORIDE |
| Manufacturer | NuCare Pharmaceuticals,Inc. |
| Used for | INDICATIONS AND USAGE Clindamycin is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. Clindamycin is also indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci, and staphylococci. Its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgment of the physician, a penicillin is inappropriate. Because of the risk of colitis, as described in the BOXED WARNING, before selecting clindamycin, the physician should consider the nature of the infection and the suitability of less toxic alternatives (e.g., erythromycin). Anaerobes: Serious respiratory tract infections su |
| Dosage | DOSAGE AND ADMINISTRATION If significant diarrhea occurs during therapy, this antibiotic should be discontinued (see BOXED WARNING ). Adults : Serious infections – 150 to 300 mg every 6 hours. More severe infections – 300 to 450 mg every 6 hours. Pediatric Patients (for children who are able to swallow capsules): Serious infections – 8 to 16 mg/kg/day (4 to 8 mg/lb/day) divided into three or four equal doses. More severe infections – 16 to 20 mg/kg/day (8 to 10 mg/lb/day) divided into three or f |
| Warnings | WARNINGS See BOXED WARNING Clostridioides difficile- Associated Diarrhea Clostridioides difficile -associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents, including clindamycin hydrochloride, and may range in severity from mild diarrhea to fatal colitis. Treatment with antibacterial agents alters the normal flora of the colon, leading to overgrowth of C. difficile . C. difficile produces toxins A and B, which contribute to the development of CDAD. Hypertoxin pro |
| Active ingredient(s) | CLINDAMYCIN HYDROCHLORIDE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=11e8dd9c-81fd-4e88-e063-6294a90af13e |